pneumocandin B(0)

Known as: pneumocandin B0, pneumocardin B(0) 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2016
0119962016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
In this work, we prepared surface molecularly imprinted polymer (MIP) for selective recognition of pneumocandin B0 (PNB0… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2005
Review
2005
Caspofungin, a semisynthetic derivative of the pneumocandin B(0), is the first licensed compound of a new class of antifungal… (More)
Is this relevant?
2000
2000
Besides the antifungal agents variotin (1), wasabidienone B(0) (4), and phomaligin A (5), two new but inactive metabolites… (More)
Is this relevant?
1997
1997
The in vitro activity of the new antifungal drug pneumocandin L-743,872 against 55 isolates of clinically important molds was… (More)
Is this relevant?
1997
1997
Serious fungal infections are increasingly common in immunocompromised patients and existing antifungals do not completely… (More)
Is this relevant?
1996
1996
  • F. Toppan
  • 1996
It is shown how to obtain superconformal Toda models as reductions of WZNW theories based on any Lie or super–Lie algebra… (More)
Is this relevant?